![]() |
市場調查報告書
商品編碼
1736520
全球電子阿斯匹靈市場-按疼痛類型、最終用戶、地區分類的市場規模,預測至 2025 年Global Electronic Aspirin Market Size By Pain Type (Migraines, Cluster Headaches), By End-User (Hospitals, Clinics), By Geographic Scope And Forecast |
2024 年電子阿斯匹靈市場規模價值 46.7 億美元,預計到 2032 年將達到 63.3 億美元,預測期內(2026-2032 年)的複合年成長率為 5.89%。
推動市場成長的關鍵因素包括技術進步,以及患有持續性臉部頭痛、叢集性頭痛和偏頭痛等疾病的人數不斷增加。此外,生活方式的改變和工作壓力也是導致這些疾病案例上升的其他因素,預計這些因素將在預測期內對市場成長產生積極貢獻。全球電子阿斯匹靈市場報告對市場進行了全面的評估,對關鍵細分市場、趨勢、市場促進因素、競爭格局以及影響市場的關鍵因素進行了全面的分析。
全球電子阿斯匹靈市場定義
電子阿斯匹靈是由Automatic Technologies公司開發的醫療設備,有助於緩解偏頭痛、頭痛和緊張性頭痛等症狀引起的疼痛。電子阿斯匹靈是一種模擬神經的植入,連接到位於牙齦上方骨腔深處的翼腭神經節(SPG)。該裝置透過微創手術植入,並由手持設備控制。該裝置發出低強度的電子脈衝,刺激神經末梢並幫助阻斷疼痛感受器。
預測期內,預計推動市場成長的主要因素包括:對偏頭痛等症狀的認知度不斷提高、技術進步以及產品認證數量的增加。此外,全球神經系統疾病盛行率的上升以及政府措施不斷增多,預計將進一步促進市場成長。
全球電子阿斯匹靈市場概況
偏頭痛(一種通常導致大腦一側搏動性或搏動性疼痛的頭痛)的盛行率日益上升,是該裝置的主要用途。偏頭痛通常伴隨嘔吐、噁心以及對聲音和光線的極度敏感。偏頭痛的預防性治療通常包括藥物、注射、皮膚貼片和滴鼻劑,這些有助於在症狀出現後控制症狀。該疾病的高盛行率預計將支持市場的成長。例如,根據美國國家醫學圖書館的報導,偏頭痛是最常見的神經系統疾病之一,影響全球超過10億人。這種疾病在年輕人和女性中更為常見。
此外,頭痛和工作壓力的增加預計將推動該設備的需求。根據世界衛生組織 (WHO) 的數據,成年人頭痛的盛行率為 50%。此外,18 至 65 歲族群中,有一半至四分之三的人患有頭痛。其中,30% 的人患有偏頭痛。由於頭痛是常見現象,大多數人會選擇自行用藥,包括服用眾所周知的止痛藥阿斯匹靈。
Electronic Aspirin Market size was valued at USD 4.67 Billion in 2024 and is projected to reach USD 6.33 Billion by 2032, growing at a CAGR of 5.89% during the forecast period 2026-2032.
Major factors which drive the market growth include advances in technology, and a growing number of people suffering from conditions such as ongoing facial headaches, cluster headaches, and migraine. Moreover, changing lifestyles and work-related stress are some of the other factors that are increasing the instances of these conditions, which is expected to positively contribute to the growth of the market during the forecast period. The Global Electronic Aspirin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Electronic Aspirin Market Definition
Electronic Aspirin is a medical device developed by Automatic Technologies that helps to alleviate pain from conditions such as migraines, headaches, and tension headaches. Electronic aspirin is a nerve-simulated implant that is connected to the Sphenopalatine Ganglion (SPG) which is a collection of nerves deep in the bone cavity of the upper gum. The device is implanted through a minimally invasive procedure and is controlled through a handheld device. The device sends low-level electronic impulses that stimulate the nerve endings that help to block the pain receptors.
Growing awareness about conditions such as migraines, technological advancement, and increasing product approvals are some of the key factors which are expected to contribute to the growth of the market during the forecast period. Moreover, the increasing prevalence of neurological conditions globally and increasing government initiatives in order to improve awareness are expected to further contribute to the growth of the market.
Global Electronic Aspirin Market Overview
The increasing prevalence of migraine a headache that causes pulsating sensation or throbbing pain usually on one side of the brain is a key condition for which the device is used. Migraine is usually accompanied by vomiting, nausea, and extreme sensitivity to sound and light. Preventive treatment for the condition usually involves drugs, injections, skin patches, and nasal sprays that help to stop the condition after its onset. The high prevalence of the condition is expected to support the growth of the market. For instance, according to an article by the National Library of Medicine, Migraine is one of the most common neurological disorders that affects more than 1 billion people globally. The condition is most common in young adults and females.
Moreover, increasing instances of headaches and work-related stress are expected to support the demand for the devices. According to the World Health Organization, the prevalence of headaches among adults was 50%. Moreover, half or three-quarters between the age of 18-65 suffer from headaches. Among this population, 30% of these individuals are reported to suffer from migraine. Due to headaches being a common phenomenon most people resort to self-medication which includes Aspirin which is a well-known analgesic.
The Global Electronic Aspirin Market is segmented based on Pain Type, End-User, And Geography.
Based on the Pain Type, The market is bifurcated into Migraines, Cluster Headaches, and Head and Facial Pain. The cluster headaches segment is expected to dominate during the forecast period owing to the higher prevalence of the condition among the population due to changing lifestyles and increasing work-related stress. For instance, according to an article by the American Institute of Stress, more than 40% of workers have reported job stress.
Based on End-User, The market is bifurcated into Hospitals, Clinics, and Ambulatory Surgical Centers. The hospital segment held the largest share in 2022 due to the higher number of people undergoing treatment for conditions at the hospitals. Moreover, the availability of advanced infrastructure and favorable reimbursement policies are expected to support the growth of the segment during the forecast period.
Based on Geography, The Global Electronic Aspirin Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest market in the global Electronic Aspirin Market this is attributed to the growing prevalence of neurological conditions, headaches, and migraines among the populations in the region. Moreover changing lifestyle and increasing work-related stress among young adults and adults is expected to positively impact the growth of the market.
The "Global Electronic Aspirin Market" study report will provide valuable insight with an emphasis on the global market. Autonomic Technologies, Inc. Cefaly Technology, Omron Healthcare, TheraGun, Cochlear Limited, and Neurostim are the sole companies operating in the market.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.